ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
58,948.04
-0.29%
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs Yen
153.0935
0.03%
Brent Oil
83.875
0.29%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Atara Biotherapeutics Inc (ATRA)

  7. Atara Biotherapeutics Inc (ATRA) ニュース

ATRA Atara Biotherapeutics Inc

0.6996
0.0493 (7.58%)
プレマーケット
最終更新日： 19:54:50
15分遅延
名称 銘柄コード 市場 種別
Atara Biotherapeutics Inc ATRA NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
Upgrade Icon
0.0493 7.58% 0.6996 19:54:50
始値 安値 高値 終値 前日終値
0.6503
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0605:01BWAtara Biotherapeutics, Inc. Reports Inducement Grant Under..
2024/3/2821:30BWAtara Biotherapeutics Announces Fourth Quarter and Full Year..
2024/3/0708:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0708:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0510:21EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0510:19EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0510:18EDGAR2Form 144 - Report of proposed sale of securities
2024/3/0510:17EDGAR2Form 144 - Report of proposed sale of securities
2024/2/2923:05BWAtara Biotherapeutics Receives FDA Clearance of IND..
2024/2/2906:30BWAtara Biotherapeutics to Participate in Cell Therapy Panel..
2024/2/2406:30EDGAR2Form 8-K - Current report
2024/2/1423:00BWAtara Biotherapeutics Announces Submission of..
2024/2/0116:25PRNUSAtara Biotherapeutics and Pierre Fabre Laboratories Announce..
2024/2/0108:30BWAtara Biotherapeutics and Pierre Fabre Laboratories Announce..
2024/1/1006:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1006:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1006:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1006:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1006:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1006:28EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/1006:01EDGAR2Form 8-K - Current report
2024/1/0823:00BWAtara Biotherapeutics Announces $15 Million Registered..
2024/1/0822:11EDGAR2Form 8-K - Current report
2024/1/0822:00BWAtara Biotherapeutics to Present Recent Progress and Key..
2024/1/0506:01BWAtara Biotherapeutics to Present at the 42nd Annual J.P...
2024/1/0406:09EDGAR2Form S-8 - Securities to be offered to employees in employee..
2023/12/2106:30EDGAR2Form 8-K - Current report
2023/12/2106:01BWAtara Biotherapeutics Announces Closing of Expanded Global..
2023/12/1202:00BWAtara Biotherapeutics Presents Positive Preclinical Data on..
2023/12/0206:01BWAtara Biotherapeutics, Inc. Reports Inducement Grants Under..
2023/11/3008:05BWAtara Biotherapeutics To Present Positive New Tab-cel®..
2023/11/2306:01BWAtara Biotherapeutics to Participate at the 6th Annual..
2023/11/2107:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2107:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2107:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2107:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2107:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/2107:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/11/1806:31EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2023/11/1414:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/11/1106:01BWAtara Biotherapeutics To Participate at the Stifel..
2023/11/0907:35BWAtara Biotherapeutics Announces Primary Analysis Data from..
2023/11/0206:25EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/11/0205:05EDGAR2Form 8-K - Current report
2023/11/0121:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0121:35EDGAR2Form 8-K - Current report
2023/11/0121:30BWAtara Biotherapeutics Announces Expanded Global Tab-cel®..
2023/10/0705:01BWAtara Biotherapeutics, Inc. Reports Inducement Grants Under..
2023/9/2005:50DJNAtara Biotherapeutics to Submit New FDA Biologics License..
2023/9/2005:01BWAtara Biotherapeutics Announces Plans to Submit Tab-cel® BLA..

最近閲覧した銘柄

NASDAQ
ATRA
Atara Biotherapeutics
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有